WEEKLY NEWSLETTER

Health's Top Stories
Get a weekly look at the most popular stories on Health.com.

Irritable Bowel Syndrome (IBS)


content provided by Healthwise

References

Citations

  1. Longstreth GF, et al. (2006). Irritable bowel syndrome section of Functional bowel disorders. In DA Drossman et al., eds., Rome III: The Functional Gastrointestinal Disorders, 3rd ed., pp. 490–509. McLean, VA: Degnon Associates.

  2. Talley NJ (2008). Functional gastrointestinal disorders: Irritable bowel syndrome, dyspepsia, and noncardiac chest pain. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 990–998. Philadelphia: Saunders Elsevier.

  3. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002). Evidence-based position statement on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology, 97(11, Suppl): S1–S26.

  4. Olden KW (2002). Diagnosis of irritable bowel syndrome. Gastroenterology, 122(6): 1701–1714.

  5. Tack J (2006). Irritable bowel syndrome. In MM Wolfe et al., eds., Therapy of Digestive Disorders, 2nd ed., pp. 701–710. Philadelphia: Saunders Elsevier.

  6. Brandt LJ, et al. (2002). Systematic review on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology, 97(11, Suppl): S7–S26.

  7. Spanier JA, et al. (2003). A systematic review of alternative therapies in the irritable bowel syndrome. Archives of Internal Medicine, 163(3): 265–274.

  8. Liu JP, et al. (2006). Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

  9. Lim B, et al. (2006). Acupuncture for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews (4). Oxford: Update Software.

  10. Sharara AI, et al. (2006). A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. American Journal of Gastroenterology, 101(2): 326–333.

Other Works Consulted

  • Chang I, et al. (2005). A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. American Journal of Gastroenterology, 100(1): 115–123.

  • Friedel D, et al. (2001). Ischemic colitis during treatment with alosetron. Gastroenterology, 120(2): 557–560.

  • Spanier JA, et al., (2003). A systematic review of alternative therapies in the irritable bowel syndrome. Archives of Internal Medicine, 163: 265–274.

  • Talley NJ (2006). Irritable bowel syndrome. In M Feldman et al., eds., Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th ed., vol. 2, pp. 2633–2652. Philadelphia: Saunders Elsevier.



Last Updated: May 23, 2008
Author:
Monica Rhodes
Medical Review:
Kathleen Romito, MD - Family Medicine

Arvydas D. Vanagunas, MD - Gastroenterology


© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.



This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.